|
1.Hepatitis B
vaccine (HepB).
• Administer the 3-dose series to those who were not
previously vaccinated.
• A 2-dose series of Recombivax HB® is licensed for children
aged 11–15 years.
2. Rotavirus vaccine
(Rota).
• The maximum
age for the first dose is 14 weeks 6 days. Vaccination should
not be initiated for
infants aged 15 weeks or older (i.e., 15 weeks 0 days or older).
• Administer the final dose in the series by age 8 months 0
days.
• If Rotarix®
was administered for the first and second doses, a third dose is
not indicated.
3. Diphtheria and tetanus toxoids and acellular pertussis
vaccine (DTaP).
• The fifth dose is not necessary if the fourth dose was
administered at age 4 years or older.
4. Haemophilus influenzae type b conjugate vaccine (Hib).
• Vaccine is not generally recommended for children aged 5 years
or older.
• If current age is younger than 11 months and the first 2 doses
were PRP-OMP (PedvaxHIB® or ComVax® [Merck]), the third (and
final) dose should be administered at age 12–15 months and at
least 8 weeks after the second dose.
• If first dose was administered at age 7–11 months, administer
2 doses separated by 4 weeks plus a booster at age 12–15 months.
5.
Pneumococcal conjugate vaccine (PCV).
• Administer one dose of PCV to all healthy children aged 24–59
months who have not received at least 1 dose of PCV at ≥ 12
months.
• For children aged 24 through 59 months with underlying
medical conditions, administer 1 dose of PCV if 3 doses were received
previously or administer 2 doses of PCV at least 8 weeks apart
if fewer than 3 doses were received previously.
• Administer pneumococcal polysaccharide vaccine (PPSV) to
children aged 2 years or older with certain
underlying medical conditions (see MMWR 2000;49[No.
RR-9]), including a cochlear implant, at least 8 weeks after the
last dose of PCV.
6.
Inactivated poliovirus vaccine (IPV).
• For children who received an all-IPV or all-oral poliovirus (OPV)
series, a fourth dose is not necessary if third dose was
administered at age 4 years or older.
• If both OPV and IPV were administered as part of a series, a
total of 4 doses should be administered, regardless of the
child’s current age.
7.
Measles, mumps, and rubella vaccine (MMR).
• The second dose of MMR is recommended routinely at age 4–6
years. However, the second dose may be administered
before age 4, provided at least 28 days have elapsed since the
first dose.
• If not previously vaccinated, administer 2 doses with at lease 28 days between the doses.
8. Varicella vaccine.
• The second dose of varicella vaccine is recommended routinely
at age 4–6 years. However, the second dose may be administered
before age 4, provided at least 3 months have elapsed since the
first dose.
• For persons aged 12 months through 12 years, the
minimum interval between doses is 3 months. However, if the
second dose was administered at least 28 days after the first
dose, it can be accepted as valid.
• For persons aged 13 years and older, the minimum interval
between doses is 28 days.
9. Hepatitis A vaccine
(HepA).
• HepA is recommended for children > age 1 year who live
in areas where vaccination programs target older children. See
MMWR 2006;55(No. RR-7):1–23.
10. Tetanus and diphtheria toxoids vaccine (Td) and tetanus and
diphtheria toxoids and acellular pertussis vaccine (Tdap).
• Doses of DTaP are counted as part of the Td/Tdap series.
• Tdap should be substituted for a single dose of Td in the
catch-up series or as a booster for children aged 10 through 18
years; use Td for other doses.
11. Human
papillomavirus vaccine (HPV).
• Administer the HPV vaccine series to females at age 13–18
years if not previously vaccinated.
• Use recommended
routine dosing intervals for series catch-up (i.e., the second
and third doses should be administered at 2 and 6 months after
the first dose). However, the minimum interval between the first
and second doses is 4 weeks. The minimum interval between the
second and third doses is 12 weeks, and the third dose should be
given at least 24 weeks after the first dose.
|
